Common Contracts

CG ONCOLOGY, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (AS AMENDED) DATED: July 28, 2023

Investors’ Rights Agreement • January 18th, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Investors’ Rights Agreement
• Filed
  January 18th, 2024
• Company
  CG Oncology, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of July 28, 2023 by and among CG ONCOLOGY, INC., a Delaware corporation (the “Company”), as amended, and the investors listed on Schedule A hereto (each an “Investor” and collectively the “Investors”).

CG ONCOLOGY, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT DATED: July 28, 2023

Investors’ Rights Agreement • January 2nd, 2024 • CG Oncology, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Investors’ Rights Agreement
• Filed
  January 2nd, 2024
• Company
  CG Oncology, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of July 28, 2023 by and among CG ONCOLOGY, INC., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto (each an “Investor” and collectively the “Investors”).